Home β€Ί Stock analysis β€Ί MDXH

MDxHealth SA (MDXH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

MDXH slides 65.8% to $0.21, a 52-week low on 2.3x normal volume. Closed at $0.21, -65.79% vs the prior close of $0.60. Day range $0.19–$0.41, opened at $0.40.

Last close$0.21-65.79%
Day range0.19–0.41
Open0.40
Volume16.89M
52-week range0.19–5.33
Avg volume (20d)1.08M

MDXH daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” MDXH slides 65.8% to $0.21, a 52-week low on 2.3x normal volume
Oct 15, 2026 β€” MDXH slides 4.4% to $0.60
Oct 14, 2026 β€” MDXH slides 4.2% to $0.63
Oct 13, 2026 β€” MDXH jumps 9.3% to $0.66, 3 up days in a row
Oct 12, 2026 β€” MDXH rises 2.4% to $0.60
Oct 9, 2026 β€” MDXH rises 1.5% to $0.59
Oct 8, 2026 β€” MDXH slides 3.2% to $0.58
Oct 7, 2026 β€” MDXH ends flat (+0.0%) to $0.60
Oct 6, 2026 β€” MDXH rises 0.5% to $0.60
Oct 5, 2026 β€” MDXH jumps 4.6% to $0.60
Oct 2, 2026 β€” MDXH dips 0.9% to $0.57

MDXH latest news & SEC filings

Every SEC filing by or about MDXH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 16, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-109977

Oct 15, 2026 Β· Form SCHEDULE 13D/A β€” Update to a 13D 5%+ stake disclosure

Update to a 13D 5%+ stake disclosure

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001420506-26-002323

Sep 17, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001178937-26-000045

Sep 3, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-097170

Aug 17, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000935836-26-000425

Aug 17, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-354021

Aug 14, 2026 Β· Form SCHEDULE 13D β€” Activist-style stake (13D)

Activist-style stake (13D) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001171520-26-000229

Aug 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-089082

Aug 13, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-089071

Aug 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-089069

Aug 13, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000935836-26-000393

Jul 24, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-081499

Jul 8, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001535264-26-000037

Jul 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-074980

Things to know before you trade MDXH

MDXH market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20260.400.410.190.2116.89M
Oct 15, 20260.640.650.580.60782.70K
Oct 14, 20260.670.680.630.63211.60K
Oct 13, 20260.600.670.600.66488.50K
Oct 12, 20260.580.610.580.60294.00K
Oct 9, 20260.570.600.570.5948.10K
Oct 8, 20260.600.610.570.5859.20K
Oct 7, 20260.590.610.590.60332.90K
Oct 6, 20260.610.610.590.60184.40K
Oct 5, 20260.570.610.560.60126.20K
Oct 2, 20260.570.600.560.5778.10K
Oct 1, 20260.600.600.560.58117.80K
Sep 30, 20260.520.640.520.58451.20K
Sep 29, 20260.530.550.520.52311.00K
Sep 28, 20260.560.570.550.5594.70K
Sep 25, 20260.580.600.560.56235.10K
Sep 24, 20260.610.610.560.58222.70K
Sep 23, 20260.600.620.580.61106.50K
Sep 22, 20260.640.640.590.60314.20K
Sep 21, 20260.630.650.600.60347.70K

About MDxHealth SA

MDxHealth SA (MDXH) is listed on the Nasdaq and classified by the SEC under β€œServices-Medical Laboratories”. Its business address is in HERSTAL, Belgium. State of incorporation: Belgium. Fiscal year ends β€”. SEC CIK 1872529.

MDXH board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Eric BednarskiDirectorAug 17, 2026
Don M HardisonDirectorJun 3, 2026
Koen HoffmanDirectorJun 3, 2026
Michael HolderDirectorJun 3, 2026
Partners, Llc MvmDirectorAug 17, 2026
Michael McgarrityChief Executive OfficerJun 3, 2026
Sanford Jay SiegelDirectorJun 3, 2026
Hilde WindelsDirectorJun 3, 2026

Executive officers

NameTitleLatest filing
John BellanoChief Commercial OfficerJun 3, 2026
Ron KalfusChief Financial OfficerApr 13, 2026
Michael McgarrityChief Executive OfficerJun 3, 2026
Brendan OconnellVP, Finance and AccountingJun 3, 2026
Joseph SolleeSee RemarksJun 3, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 13, 2026Eric BednarskiBuy2,202,643$0.45
Aug 13, 2026Eric BednarskiBuy2,202,643$0.45
Aug 13, 2026Partners, Llc MvmBuy2,202,643$0.45
Aug 13, 2026Partners, Llc MvmBuy2,202,643$0.45
Aug 13, 2026Eric BednarskiBuy2,202,643$0.45
Aug 13, 2026Eric BednarskiBuy2,202,643$0.45
Aug 13, 2026Partners, Llc MvmBuy2,202,643$0.45
Aug 13, 2026Partners, Llc MvmBuy2,202,643$0.45

MDXH financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

MDXH earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Services-Medical Laboratories

Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on MDXH

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.